Type 2 Diabetes Mellitus
Showing 26 - 50 of 1,595
LabPatch Glucose Sensing System in Insulin-treated Diabetes
Recruiting
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- 2nd Gen LabPatch Glucose Sensing System
-
Boston, MassachusettsJoslin Diabetes Center
Feb 22, 2023
Type 2 Diabetes Trial (SGLT2 inhibitor)
Not yet recruiting
- Type 2 Diabetes Mellitus
- SGLT2 inhibitor
- (no location specified)
Feb 12, 2023
Type 2 Diabetes Trial in Kubang Kerian (Althernanthera Sissoo, Dietary Consultation)
Recruiting
- Type 2 Diabetes Mellitus
- Althernanthera Sissoo
- Dietary Consultation
-
Kubang Kerian, Kelantan, MalaysiaHospital Universiti Sains Malaysia
Feb 3, 2023
Obesity, Overweight, Type 2 Diabetes Trial in Tustin, Honolulu (AMG 133, Placebo)
Recruiting
- Obesity
- +2 more
- AMG 133
- Placebo
-
Tustin, California
- +1 more
Feb 1, 2023
Type 2 Diabetes Trial in Beijing (GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment)
Recruiting
- Type 2 Diabetes Mellitus
- GA guided anti-diabetic therapy adjustment
- current guidelines to adjust treatment
-
Beijing, China
- +9 more
Jan 30, 2023
s to Learn More About Treatment With Steroidal Mineralocorticoid
Active, not recruiting
- Chronic Kidney Disease
- +2 more
- sMRA therapies
-
Whippany, New JerseyMany Locations
Jan 30, 2023
Chronic Kidney Disease, Type 2 Diabetes Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))
Not yet recruiting
- Chronic Kidney Disease
- Type 2 Diabetes Mellitus
- Finerenone (Kerendia, BAY94-8862)
-
Multiple Locations, IndiaMany Locations
Jan 20, 2023
Called FIRST-2.0 to Learn More About Use of Study Treatment
Not yet recruiting
- Chronic Kidney Disease
- Type 2 Diabetes Mellitus
- Finerenone (Kerendia, BAY948862)
-
Whippany, New JerseyOptum electronic health records (EHR) database
Jan 20, 2023
Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Riyadh
Recruiting
- Nonalcoholic Fatty Liver Disease
- Type 2 Diabetes Mellitus
-
Riyadh, Select A State Or Province, Saudi ArabiaKing Fahad Medical City
Jan 25, 2023
Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)
Not yet recruiting
- Type 2 Diabetes Mellitus
- INS068 injection
- Insulin Glargine
- (no location specified)
Jan 19, 2023
Type 2 Diabetes Trial in United States (Insulin glargine/Lixisenatide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Insulin glargine/Lixisenatide
-
Canyon Country, California
- +17 more
Jan 24, 2023
Triglyceride Glucose Index and HOMA IR as Predictors of Vascular
Not yet recruiting
- Type 2 Diabetes Mellitus
- triglyceride glucose index and HOMA IR
- (no location specified)
Jan 20, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Type 2 Diabetes Trial in London (device, behavioral, other)
Completed
- Type 2 Diabetes Mellitus
- Huma
- +3 more
-
London, United Kingdom
- +6 more
Jan 20, 2023
Type 2 Diabetes, Chronic Kidney Diseases Trial in United States (Renal Autologous Cell Therapy (REACT®))
Recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
-
Downey, California
- +23 more
Jan 18, 2023
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
-
Birmingham, Alabama
- +646 more
Jan 18, 2023
Type 2 Diabetes Trial in India (dapagliflozin and saxagliptin)
Active, not recruiting
- Type 2 Diabetes Mellitus
- dapagliflozin and saxagliptin
-
Bangalore, India
- +8 more
Jan 17, 2023
Called SMART-Finder to Look for People With Increased Amounts of
Not yet recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
- Finerenone (Kerendia, BAY94-8862)
- Type 2 DM drugs
-
Multiple Locations, GermanyMany locations
Jan 13, 2023
Type 2 Diabetes Trial (Connected Solution with H2S app which connects with blood glucose meter (BGM))
Not yet recruiting
- Type 2 Diabetes Mellitus
- Connected Solution with H2S app which connects with blood glucose meter (BGM)
- (no location specified)
Jan 12, 2023
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as
Recruiting
- Type 2 Diabetes Mellitus
- Genotyping
-
Sohag, EgyptSohag Univversity
Jan 12, 2023
Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- dapagliflozin
- Placebo
-
Seattle, WashingtonUniversity of Washington
Jan 9, 2023
Type 2 Diabetes, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT®))
Not yet recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jan 6, 2023
Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Renal Autologous Cell Therapy (REACT®))
Completed
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
- Renal Autologous Cell Therapy (REACT)
-
Tucson, Arizona
- +3 more
Jan 6, 2023